---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/38423600.md"
description: "$Novo Nordisk AS(NVO.US) The price difference between Eli Lilly and Novo is more than ten times. Eli Lilly's weight-loss drug sales have just surpassed Novo's. Compared with Eli Lilly, Novo still has a lot of room for growth. I'm preparing to go long with a call option, waiting to see if there's a chance tonight."
datetime: "2026-02-04T05:02:50.000Z"
locales:
  - [en](https://longbridge.com/en/topics/38423600.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/38423600.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/38423600.md)
author: "[Xinghai](https://longbridge.com/en/profiles/22267024.md)"
---

# $Novo Nordisk AS(NVO.US) The price difference betw…


### Related Stocks

- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)

## Comments (4)

- **邪恶小黑猫 · 2026-02-04T09:52:43.000Z**: This is quite uncertain to say, some companies are just easily hyped
  - **Xinghai** (2026-02-04T10:27:05.000Z): Novo is still worth looking forward to, especially after integrating AI, R&D costs have dropped sharply. If you're worried about catching a falling knife, you can wait a couple of days to see the 
- **白築慕的交易员 · 2026-02-04T07:16:19.000Z**: Look at the stock price but not the market cap? 🧐
  - **Xinghai** (2026-02-04T10:30:37.000Z): The market value is also several times higher, which is relatively more cost-effective. According to God's will, the future is promising.